HBXIP promotes gastric cancer via METTL3-mediated MYC mRNA m6A modification
Figure 8.Mechanism diagram illustrating that HBXIP increased the expression pattern of MYC by mediating METTL3-mediated m6A modification of MYC mRNA, thereby promoting the occurrence and development of GC.